Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
treatment? Here is your chance to contribute to science that makes a difference! The Cresswell Group is recruiting a PhD student (f/m/d) interested in bioinformatics, cancer genomics and tumor evolution
-
. Background: Many enzymes feature substrate binding domains that are not part of their active site and located in a different domain. Cellulosic and hemicellulosic enzymes often feature carbohydrate binding
-
. You must have a two-year master's degree (120 ECTS points) or a similar degree with an academic level equivalent to a two-year master's degree in a relevant field, such as bioinformatics, biochemistry
-
, expertise centres and museums around the world. has a staff of diverse colleagues in various functions and with many different nationalities, with whom you will work together in an informal atmosphere
-
will be doing In adult mammals, including humans, fibrosis is the predominant response to many forms of tissue injury, unlike many lower vertebrates and invertebrates, where complete tissue repair is the
-
, engineering, bioinformatics, machine learning, artificial intelligence) to support minimally invasive and targeted preventive and predictive medicine capable of limiting age-related functional disorders
-
interdisciplinary project, combining molecular biology, immunology, genetics, and advanced bioinformatics, working between the Bateson Centre for Disease Mechanisms, School of Biosciences and the Medical School
-
the microbial balance in different conditions and niches, we are willing to uncover new ways to boost their natural defenses helping reduce antibiotic treatments in the farm. Join us to contribute to a pioneering
-
objective of the project is to understand the underlying soil physical and microbial mechanisms governing changes in soil organic carbon stocks and greenhouse gas emissions under different types
-
. Molecular analysis of different cohorts of lung cancer patients. Animal experimentation (generation of PDX, humanized PDX, xenografts and genetically modified models), use of these models as a preclinical